Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil

Tissue Antigens

Volumn 72, Issue 5, 2008, Pages 478-482

  Franceschi, D S A ^a   Mazini, P S ^a   Rudnick, C C C ^a   Sell, A M ^a   Tsuneto, L T ^a   De Melo, F C ^a   Braga, M A ^a   Peixoto, P R F ^b   Visentainer, J E L ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b 15a Regional de Saúde Da Secretaria de Saúde Do Estado Do Paraná   (Brazil)

Author keywords

HLA class I; KIR genes; Leprosy; Natural killer cell

Indexed keywords

HLA ANTIGEN; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ADULT; ARTICLE; BRAZIL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE SEQUENCE; GENOTYPE; HUMAN; LEPROMATOUS LEPROSY; LEPROSY; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE; TUBERCULOID LEPROSY;

ADULT; BRAZIL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LEPROSY; MALE; MIDDLE AGED; RECEPTORS, KIR;

EID: 54049150355     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2008.01127.x     Document Type: Article

References (29)

1. WHO. Global leprosy situation, 2007. Wkly Epidemiol Rec 2007 : 82 : 225 32.
2. Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five group system. Int J Lepr Other Mycobact Dis 1966 : 34 : 255 73.
3. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002 : 20 : 581 620.
4. Mira MT. Genetic host resistance and susceptibility to leprosy. Microbes Infect 2006 : 8 : 1124 31.
5. Alcais A, Alter A, Antoni G et al. Stepwise replication identifies a low-producing lymphotoxin-a allele as a major risk factor for early-onset leprosy. Nat Genet 2007 : 39 : 517 22.
6. Alter A, Alcais A, Abel L et al. Leprosy as a genetic model for susceptibility to common infectious diseases. Hum Genet 2008 : 123 : 227 35.
7. Martin MP, Gao X, Lee JH et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002 : 31 : 429 34.
8. Gaudieri S, DeSantis D, McKinnon E et al. Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression. Genes Immun 2005 : 6 : 683 90.
9. Lopéz-Vazquéz A, Miña-Blanco A, Martínez-Borra J et al. Interaction between KIR3DL1 and HLA-B*57 supertype alleles influences the progression of HIV-1 infection in a Zambian population. Hum Immunol 2005 : 66 : 285 9.
10. Martin MP, Qi Y, Gao X et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 2007 : 39 : 733 40.
11. Alter G, Martin MP, Teigen N et al. Differential natural killer cell - mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med 2007 : 204 : 3027 36.
12. Kakhoo SI, Thio CL, Martin MP et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004 : 305 : 872 4.
13. Montes-Cano MA, Caro-Oleas JL, Romero-Gómez M et al. HLA-C and KIR genes in hepatitis C virus infection. Hum Immunol 2005 : 66 : 1106 9.
14. López-Vazquéz A, Rodrigo L, Martínez-Borra M et al. Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection. J Infect Dis 2005 : 192 : 162 5.
15. Méndez A, Granda H, Meenagh A et al. Study of KIR genes in tuberculosis patients. Tissue Antigens 2006 : 68 : 386 9.
16. Khakoo SI, Carrington M. KIR and disease: a model system or system of models? Immunol Rev 2006 : 214 : 186 201.
17. Rajagopalan S, Long EO. Understanding how combinations of HLA and KIR genes influence disease. J Exp Med 2005 : 201 : 1025 9.
18. McVicar DW, Burshtyn DN. Intracellular signaling by the killer immunoglobulin-like receptors and Ly 49. Sci STKE 2001 : 75 : 1 9.
19. O'Connor GM, Hart OM, Gardiner CM. Putting the natural killer cell in its place. Immunology 2005 : 117 : 1 10.
20. Boyton RJ, Altmann DM. Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin Exp Immunol 2007 : 149 : 1 8.
21. Hansasuta P, Dong T, Thananchai H et al. Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur J Immunol 2004 : 34 : 1673 9.
22. Hsu KC, Chida S, Geraghty DE, Dupont B. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev 2002 : 100 : 40 52.
23. Parra FC, Amado RC, Lambertucci JR et al. Color and genomic ancestry in Brazilians. Proc Natl Acad Sci U S A 2003 : 100 : 177 82.
24. Uhrberg M, Valiante NM, Shum BP et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997 : 7 : 753 63.
25. Bashirova AA, Martin MP, McVicar DW, Carrington M. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genom Human Genet 2006 : 7 : 277 300.
26. Arase H, Mocarski ES, Campbell AE. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002 : 296 : 1323 6.
27. Thananchai H, Gillespie G, Martin MP. Cutting edge: allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol 2007 : 178 : 33 7.
28. Walker SL, Lockwood DN. The clinical and immunological features of leprosy. Br Med Bull 2006 : 77-78 : 103 21.
29. Parham P. MHC class I molecules and KIRs in human history, healthy and survival. Nat Rev Immunol 2005 : 5 : 201 14.